Eli Lilly and Co (NYSE:LLY)
| 325.47 BATS BZX Real-Time Price As of 1:38pm ET |  -4.54 / -1.38%Today’s Change | 224.22 Today|||52-Week Range 341.70 | +17.83% Year-to-Date |
Latest LLY News | Press Releases
Today’s Trading
| Previous close | 330.01 |
| Today’s open | 328.50 |
| Day’s range | 322.45 - 329.59 |
| Volume | 1,879,888 |
| Average volume (3 months) | 2,883,856 |
| Market cap | $295.9B |
Data as of 1:38pm ET, 09/30/2022
Growth & Valuation
| Earnings growth (last year) | -9.81% |
| Earnings growth (this year) | -1.80% |
| Earnings growth (next 5 years) | +20.80% |
| Revenue growth (last year) | +15.40% |
| P/E ratio | 51.9 |
| Price/Sales | 8.89 |
| Price/Book | 33.08 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ABBVAbbVie | -6.00 | -4.20% |
| PFEPfizer | +0.25 | +0.57% |
| MRKMerck | +0.18 | +0.21% |
| JNJJohnson & Johnson | +0.26 | +0.16% |
Data as of 1:38pm ET, 09/30/2022
Financials
| Next reporting date | November 1, 2022 |
| EPS forecast (this quarter) | $1.93 |
| Annual revenue (last year) | $28.3B |
| Annual profit (last year) | $5.6B |
| Net profit margin | 19.71% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Indianapolis, Indiana |
Forecasts
